Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

2011 Annual Meeting | Therapy of Neuromuscular Disease

Thursday 04/14/11
12:00 PM - 02:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Seminar
Carlayne E. Jackson, MD, FÂ鶹´«Ã½Ó³»­
Participants should be familiar with current recommended treatment approaches to selected peripheral neuropathies, neuromuscular junction disorders, and motor neuron diseases based on available evidence in the literature as well as expert opinion.
No CME available
Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice
Trainee, General Neurologist, Specialist Neurologist
Case-based, Audience Participation
Event Timeline
12:00 PM - 12:40 PM Amyotrophic Lateral Sclerosis: How to Treat the "Untreatable"
Carlayne E. Jackson, MD, FÂ鶹´«Ã½Ó³»­
12:00 PM - 02:00 PM Break
12:40 PM - 01:20 PM Peripheral Neuropathy: Update in Effective Therapies
Patrick M. Grogan, MD, FÂ鶹´«Ã½Ó³»­
01:20 PM - 02:00 PM Myasthenia Gravis: Treatment Options–Issues and (Some) Answers
John T. Kissel, MD, FÂ鶹´«Ã½Ó³»­
Faculty Disclosures
Carlayne E. Jackson, MD, FÂ鶹´«Ã½Ó³»­ Dr. Jackson has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Â鶹´«Ã½Ó³»­. The institution of Dr. Jackson has received research support from NIH. The institution of Dr. Jackson has received research support from Massachussetts General Hospital.
Patrick M. Grogan, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
John T. Kissel, MD, FÂ鶹´«Ã½Ó³»­ Dr. Kissel has nothing to disclose.